Cargando…
SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis
Aberrant DNA methylation is often involved in carcinogenesis. Our initial goal was to identify DNA methylation biomarkers associated with pancreatic cancer. A genomewide methylation study was performed on DNA from pancreatic ductal adenocarcinoma (PDAC) and endocrine pancreas tumors. Validation of D...
Autores principales: | Manoochehri, Mehdi, Wu, Yenan, Giese, Nathalia A., Strobel, Oliver, Kutschmann, Stefanie, Haller, Florian, Hoheisel, Jörg D., Moskalev, Evgeny A., Hackert, Thilo, Bauer, Andrea S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266283/ https://www.ncbi.nlm.nih.gov/pubmed/32243066 http://dx.doi.org/10.1002/1878-0261.12684 |
Ejemplares similares
-
GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers
por: Moskalev, Evgeny A., et al.
Publicado: (2015) -
Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer
por: Wu, Yenan, et al.
Publicado: (2021) -
Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma
por: Mustafa, Shakhawan, et al.
Publicado: (2017) -
Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022) -
Interdecadal variability in pan-Pacific and global SST, revisited
por: Tung, Ka-Kit, et al.
Publicado: (2018)